SCHEMBL10244405

SCHEMBL10244405

CS(=O)(=O)c1nc(N)nc2sccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 3/20 0.42
NTRK2 Q16620 3/20 0.42
CLK4 Q9HAZ1 3/20 0.42
CHEK1 O14757 2/20 0.42
AURKA O14965 2/20 0.42
DAPK3 O43293 2/20 0.42
JAK2 O60674 2/20 0.42
ABL1 P00519 2/20 0.42
CSF1R P07333 2/20 0.42
RET P07949 2/20 0.42
IGF1R P08069 2/20 0.42
PDGFRB P09619 2/20 0.42
PIM1 P11309 2/20 0.42
FGFR1 P11362 2/20 0.42
PRKACA P17612 2/20 0.42
KDR P35968 2/20 0.42
MAP2K2 P36507 2/20 0.42
FLT3 P36888 2/20 0.42
MAPK8 P45983 2/20 0.42
CSNK1A1 P48729 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11202541 0.73 ADORA2A (0.47) NTRK1NTRK2CLK4CHEK1AURKA
SCHEMBL10245410 0.73 DYRK1A (0.49) NTRK1NTRK2CLK4CHEK1AURKA
SCHEMBL2369026 0.72 ADORA2A (0.58) NTRK1NTRK2CLK4CHEK1AURKA
SCHEMBL30373476 0.72 ADORA2A (0.58) NTRK1NTRK2CLK4CHEK1AURKA
SCHEMBL1720111 0.70 PI4KB (0.37) GLP1R
SCHEMBL4737163 0.69 NTRK1 (0.44) NTRK1NTRK2CLK4CHEK1AURKA
SCHEMBL10244398 0.69 KMT2A (0.45) NTRK1NTRK2CLK4CHEK1AURKA
SCHEMBL5336326 0.67 PIP4K2A (0.37) NTRK1NTRK2CLK4CHEK1AURKA
SCHEMBL29994750 0.66 NTRK1 (0.41) NTRK1NTRK2CLK4CHEK1AURKA
SCHEMBL4098622 0.64 ADORA2A (0.57) CLK4CSNK1A1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221822-B2 Thiazolopyrimidine modulators as immunosuppressive agents KATHOLIEKE UNIVERSITEIT LEUVEN, K. U. LEUVEN R&D (BE) 2015-12-29 US disclosed
US-9221822-B2 Thiazolopyrimidine modulators as immunosuppressive agents KATHOLIEKE UNIVERSITEIT LEUVEN, K. U. LEUVEN R&D (BE) 2015-12-29 US disclosed
EP-2923734-A1 Purine analogues and their use as immunosuppressive agents Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2015-09-30 EP disclosed
US-20150038494-A1 Thiazolopyrimidine Modulators as Immunosuppressive Agents KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2015-02-05 US disclosed
US-20150038494-A1 Thiazolopyrimidine Modulators as Immunosuppressive Agents KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2015-02-05 US disclosed
US-8901132-B2 Thiazolopyrimidine modulators as immunosuppressive agents KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2014-12-02 US disclosed
US-8901132-B2 Thiazolopyrimidine modulators as immunosuppressive agents KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2014-12-02 US disclosed
US-20120046278-A1 THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2012-02-23 US disclosed
US-20120046278-A1 THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2012-02-23 US disclosed
WO-2010103130-A2 NOVEL BICYCLIC HETEROCYCLES KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2010-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150038494-A1 Thiazolopyrimidine Modulators as Immunosuppressive Agents TPMT, STAT6, IL4 NTRK1 3666/4885NTRK2 3790/4885CLK4 2162/4885
US-20120046278-A1 THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS TPMT, STAT6, IL4 NTRK1 3666/4885NTRK2 3790/4885CLK4 2162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.